Antipodes Partners LTD Portfolio Holdings

Antipodes Partners LTD

  • $3 Billion
  • Q2 2025

Antipodes Partners LTD has filed its 13F form on August 04, 2025 for Q2 2025 where it was disclosed a total value porftolio of $3 Billion distributed in 106 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $239M, Alphabet Inc. with a value of $202M, Capital One Financial Corp with a value of $200M, Amazon Com Inc with a value of $172M, and Hca Healthcare, Inc. with a value of $150M.

Examining the 13F form we can see an decrease of $159M in the current position value, from $3.16B to 3B.

Antipodes Partners LTD is based out at Royal Exchange, C3

Below you can find more details about Antipodes Partners LTD portfolio as well as his latest detailed transactions.

Portfolio value $3 Billion
Technology: $680 Million
Healthcare: $557 Million
Financial Services: $464 Million
Consumer Cyclical: $300 Million
Basic Materials: $231 Million
Communication Services: $227 Million
Industrials: $143 Million
Utilities: $118 Million
Other: $282 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$12.6B
$803,000 0.03% of portfolio
68,035
Q2 2025 Reduced 46.36%
$75.9B
$831,000 0.03% of portfolio
224
Q2 2025 New
$1.27B
$456,000 0.02% of portfolio
63,315
Q2 2025 Added 97.18%
$10.2B
$630,000 0.02% of portfolio
7,169
Q2 2025 Added 44.54%
$4.79B
$279,000 0.01% of portfolio
6,788
Q2 2025 Added 33.57%
$640M
$277,000 0.01% of portfolio
87,855
Q2 2025 New
$2.96B
$220,000 0.01% of portfolio
9,162
Q2 2025 Reduced 58.99%
$3.49B
$300,000 0.01% of portfolio
7,133
Q2 2025 Reduced 9.86%
$35.3B
$183,000 0.01% of portfolio
332
Q2 2025 Added 1.53%
$442M
$202,000 0.01% of portfolio
32,085
Q2 2025 Added 107.78%
$325M
$165,000 0.01% of portfolio
22,021
Q2 2025 Reduced 18.43%
Apogee Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 10.15%
Chime Financial Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$1.72B
$77,000 0.0% of portfolio
6,665
Q2 2025 Added 22.47%
$0
$0 0.0% of portfolio
2,201
Q2 2025 Reduced 25.21%
Qiagen Nv
-
$0 0.0% of portfolio
-
Q2 2025 Added 9.42%
$1.17B
$25,000 0.0% of portfolio
1,252
Q2 2025 Reduced 33.33%
Barrick Mining Corp
-
$0 0.0% of portfolio
-
Q2 2025 New
Sagimet Biosciences Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$539M
$137,000 0.0% of portfolio
17,510
Q2 2025 Added 8.31%
$120M
$95,000 0.0% of portfolio
10,261
Q2 2025 Reduced 27.56%
Waystar Holding Corp
-
$0 0.0% of portfolio
-
Q2 2025 New
$26.1B
$125,000 0.0% of portfolio
1,308
Q1 2025 Reduced 40.52%
$24.4B
$62,000 0.0% of portfolio
260
Q2 2025 Reduced 51.22%
$99.5B
$107,000 0.0% of portfolio
241
Q2 2025 Reduced 5.49%
$845M
$7,000 0.0% of portfolio
1,258
Q2 2025 Reduced 31.67%
$13.1B
$8,000 0.0% of portfolio
231
Q2 2025 New
$38.4B
$37,000 0.0% of portfolio
204
Q2 2025 New
Core Scientific Inc
-
$0 0.0% of portfolio
-
Q2 2025 New
$229B
$100,000 0.0% of portfolio
741
Q2 2025 Reduced 41.65%
$185M
$14,000 0.0% of portfolio
7,174
Q2 2025 New
$4.09B
$50,000 0.0% of portfolio
11,499
Q4 2024 Added 0.99%
Flutter Entertainment PLC
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 21.29%
$306B
$59,000 0.0% of portfolio
231
Q2 2025 Added 13.79%
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 43,111.39%
$4.73B
$107,000 0.0% of portfolio
1,814
Q2 2025 Added 3.84%
Structure Therapeutics Inc
-
$0 0.0% of portfolio
-
Q2 2025 Reduced 30.96%
$1.01B
$24,000 0.0% of portfolio
1,048
Q2 2025 Added 65.82%
$4.87B
$39,000 0.0% of portfolio
255
Q2 2025 New
$31.6B
$26,000 0.0% of portfolio
313
Q2 2025 Added 13.82%
$842M
$11,000 0.0% of portfolio
1,688
Q2 2025 Reduced 18.14%
$204M
$46,000 0.0% of portfolio
6,558
Q2 2025 Added 49.66%
$44.3B
$114,000 0.0% of portfolio
2,641
Q2 2025 Added 255.45%
$377M
$52,000 0.0% of portfolio
5,194
Q2 2025 Added 35.9%
$1.19B
$19,000 0.0% of portfolio
1,119
Q2 2025 New
$3.29B
$36,000 0.0% of portfolio
479
Q2 2025 Reduced 11.3%
$51B
$115,000 0.0% of portfolio
2,051
Q2 2025 Added 239.57%
$15.5B
$52,000 0.0% of portfolio
313
Q2 2025 Added 10.6%
$451M
$19,000 0.0% of portfolio
3,006
Q2 2025 Added 47.14%

Summary

  • Portfolio
  • No. of Stocks 106
  • Current Value $3 Billion
  • Prior Value $3.16 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 04, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 22 stocks
  • Additional Purchases 40 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 40 stocks
Track This Portfolio

Track Antipodes Partners LTD Portfolio

Follow Antipodes Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email